Oxford Cancer Analytics raised $11m in Series A funding co-led by We Venture Capital and Cross-Border Impact Ventures

Biotech Health services Software Services

Investments

11 December 2024

OxCan (company)

Biotech Health services Software Services

Total investments received (USD): 16.46m

Round value (USD): 11m

Round investors: Eka Ventures Cross Border Impact Ventures Civilization Ventures OKG Capital DigitalDx Ventures We Venture Capital

Company: OxCan

Industry: Biotech Health services Software Services

AI (big data) Biotech Health services Software Services

Investments 07 May 2025

AI (big data) Competitive Intelligence Health services Software Services

Investments 06 April 2025

AI (big data) Biotech Health services Software Services

Investments 10 March 2025

Health services Software Services

Investments 02 March 2025

AI (big data) Competitive Intelligence Hardware Health services Software Services

Investments 01 March 2025